0 item $0.00

Dr Michael Keating

BBioMedSci(hons) | PhD in Medicine, Monash University

Dr Michael Keating

Molecular Metabolism and Ageing


Monash University supervisor

Research Officer

+61 3 8532 1335

Dr Michael Keating completed his PhD jointly in the Lipid Metabolism and Cardiometabolic Disease, and the Molecular Metabolism and Aging laboratories at the Baker Institute in 2020. During his PhD studies his research focused on the discovery and characterisation of novel regulators of hepatic lipid metabolism.

Currently, Michael holds a postdoctoral position at the Baker Institute. His work involves identifying novel targets that may regulate hepatic lipid metabolism and then assessing if they have the potential to be of therapeutic benefit to humans with cardiometabolic diseases. Most recently he has worked to setup a preclinical CRISPR validation platform with an aim to streamline target section and translatability. His work has published in high impact journals including Nature and Circulation Research.


  • Baker Institute John Funder ECS Award (2022)
  • Pincus Taft Young Investigator Award Finalist (2019, 2020, 2021)
  • Australian Atherosclerosis Society Student Oral Finalist (2019)
  • Australasian Diabetes Society Travel Award (2019)
  • Alfred Health Week Senior Medical Staff Award for Basic Science (2019)
  • Alfred Health Week Prize for Cardiovascular Research (2018, 2019)
  • Harold Mitchell Travel Fellowship (2018)
  • Baker Institute Rod Andrew PhD Award (2018)
  • Australian and New Zealand Obesity Society Conference ECR Award Winner (2018)
  • Research Training Program (RTP, formerly APA) Scholarship (2018)

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more